Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

gizmodo.com - Passant Rabie - Varda's First Pharma Deal Brings Space Drugs Closer to Reality
Varda's First Pharma Deal Brings Space Drugs Closer to Reality
Gizmodo | The Future Is Here

A California-based startup has just taken its vision of in-orbit manufacturing to the big leagues, signing a major deal with a pharmaceutical company to explore developing new, improved versions of its drugs in space. Varda Space Industries…

globenewswire.com - Zealand Pharma - Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026)
Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026)
GlobeNewswire

Company announcement No. 16 / 2026 Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026) Copenhagen, Denmark, May 14, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…

axios.com - Peter Sullivan - Pharma leaders hope next FDA head calms waters
Pharma leaders hope next FDA head calms waters
Axios

The CEO of the main pharmaceutical company trade group on Wednesday called for the next Food and Drug Administration commissioner to 'calm the waters' and ensure stability as drug companies develop new treatments. Why it matters: The FDA has faced…

france24.com - Indian pharma fuels Africa's 'zombie drug' and opioid crisis
Indian pharma fuels Africa's 'zombie drug' and opioid crisis
FRANCE 24

Millions of tapentadol tablets from India are helping drive a deadly opioid epidemic ravaging the region, with officials and researchers telling AFP that they are also being added to the 'zombie drug' kush. The cheap pills are so strong that no…

seekingalpha.com - SA Transcript Insights Editor - Doximity forecasts fiscal 2027 revenue of $664M-$676M amid 'AI investment year' and softer pharma ad visibility (NYSE:DOCS)
Doximity forecasts fiscal 2027 revenue of $664M-$676M amid 'AI investment year' and softer pharma ad visibility (NYSE:DOCS)
Seeking Alpha

Earnings Call Insights: Doximity (DOCS) Q4 fiscal 2026 'Q4 ended above the high end of our guidance, with a record $107 million in free cash flow, our first ever 9-digit free cash flow quarter.' (Co-Founder, CEO & Chairperson Jeffrey Tangney)…

straitstimes.com - Indian pharma fuels Africa's 'zombie drug' and opioid crisis
Indian pharma fuels Africa's 'zombie drug' and opioid crisis
The Straits Times

NEW DELHI - They come in blister packs of 10 like any normal painkiller and you can buy them easily in roadside kiosks and street pharmacies across west Africa. Millions of tapentadol tablets from India are helping drive a deadly opioid epidemic…

247wallst.com - Trey Thoelcke - Big Pharma's 5 Hottest Biotech Hunting Grounds: Meet the Category Leaders
Big Pharma's 5 Hottest Biotech Hunting Grounds: Meet the Category Leaders
24/7 Wall St

Biotech dealmaking accelerated heading into the JPM 2026 Healthcare Conference as large drugmakers face looming patent cliffs and hunt for growth. Five therapeutic categories are absorbing most strategic capital: radiopharmaceuticals, next-gen…

thehindubusinessline.com - Alembic Pharma gets USFDA tentative approval for generic prostate cancer drug
Alembic Pharma gets USFDA tentative approval for generic prostate cancer drug
BusinessLine

Alembic Pharmaceuticals Ltd on Thursday said it has received tentative approval from the US health regulator for its generic version of Darolutamide tablets indicated for treatment of prostate cancer. The tentative approval by the U.S. Food and…

law360.com - Jaqueline McCool - Minn. Bill Seeks Pharma Marketing Fed Deduction Add-Back
Minn. Bill Seeks Pharma Marketing Fed Deduction Add-Back
Law360

Minnesota would require pharmaceutical companies to add back their federally deducted business expenses arising from marketing spending under a bill introduced in the state Senate on Wednesday. ... To view the full article, register now. Already a…

poz.com - Trent Straube - PrEP4All Lawsuit Seeks Details on Government and Pharma's HIV Prevention Agreement
PrEP4All Lawsuit Seeks Details on Government and Pharma's HIV Prevention Agreement
POZ

The national HIV advocacy group PrEP4All filed a federal lawsuit against four Trump administration agencies to force the release of an undisclosed agreement between them and pharmaceutical giant Gilead Sciences regarding HIV prevention research and…

forbes.com - Tarek Waked - From Missions To Markets: Making Space Visible And Accessible
From Missions To Markets: Making Space Visible And Accessible
Forbes

Tarek Waked, Co-Founder & Managing Partner at Type One Ventures. I've argued that space's first true AI-style inflection will be driven by rapid orbital reusability. I still believe that. If anything, the idea is stronger now. However, what has…

rediff.com - Nandita Malik - Sensex Rallies: Telecom, Banking Shares Propel Market Recovery Amid Volatility
Sensex Rallies: Telecom, Banking Shares Propel Market Recovery Amid Volatility
Rediff.com

Indian stock markets witnessed a robust recovery, with the Sensex surging nearly 790 points, as strong buying in telecom, pharma, and private banking shares propelled the benchmark indices higher despite intraday volatility and a record-low rupee.

globenewswire.com - 4basebio - 4basebio Announces Appointment of Chief Financial Officer and Board Changes
4basebio Announces Appointment of Chief Financial Officer and Board Changes
GlobeNewswire

Richard Bungay appointed as CFO, bringing a strong track record in fundraising, M&A and partnering for listed and private companies, including two major exits and over $400m raised Cambridge, UK, 14 May 2026 – 4basebio PLC (AIM: 4BB), a…

seekingalpha.com - Niloofer Shaikh - Biggest stock movers Thursday: CSCO, DOCS, and more (NYSE:DOCS)
Biggest stock movers Thursday: CSCO, DOCS, and more (NYSE:DOCS)
Seeking Alpha

Cisco's AI restructuring, job cuts, and raised guidance boosted shares due to optimism about realignment toward high-growth AI infrastructure. Doximity's outlook indicated slowing growth, especially in ad and pharma spending on its healthcare…

rediff.com - Rediff News - Sensex jumps nearly 790 points
Sensex jumps nearly 790 points
Rediff.com

Stock markets rose for the second consecutive day on Thursday with the benchmark Sensex jumping by nearly 790 points in a volatile session, driven by value buying in telecom, pharma and private banking shares. The 30-share BSE Sensex jumped 789.74…

Receive a Daily briefing on Pharma Industry News

Get Started